Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pMCL-HA-MAPKK1-11A55B [S218E/S222D] Citations (2)

Originally described in: Transformation of mammalian cells by constitutively active MAP kinase kinase.
Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG Science. 1994 Aug 12;265(5174):966-70. PubMed Journal

Articles Citing pMCL-HA-MAPKK1-11A55B [S218E/S222D]

Articles
Extracellular signal-regulated kinase activation during cardiac hypertrophy reduces sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) transcription. Huang H, Joseph LC, Gurin MI, Thorp EB, Morrow JP. J Mol Cell Cardiol. 2014 Oct;75:58-63. doi: 10.1016/j.yjmcc.2014.06.018. Epub 2014 Jul 6. PubMed
Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance. Greaves SA, Peterson JN, Torres RM, Pelanda R. Front Immunol. 2018 Apr 9;9:707. doi: 10.3389/fimmu.2018.00707. eCollection 2018. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.